Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics ("RevOpsis"), a nex ...
Media outlets endured an hour of marketing waffle, during which they were introduced to the company’s bizarre new logo and branding, as well as the concept set to debut on December 2 ...